WFA’s ability to modulate key pathways, such as reactive oxygen species (ROS) production and NF-κB activity, may play a crucial role in sensitizing pancreatic cancer cells to FOLFIRINOX, particularly in cases where resistance has developed. This evidence concerns the gene NFKB1 and familial pancreatic carcinoma.